Melita Sun Jung

Chief Business Officer, Structure Therapeutics Inc.

Companies

Terns Pharmaceuticals, Inc.Chief Business Officer May 2, 2024 to now¹
Structure Therapeutics Inc.Chief Business Officer Feb 2, 2023 to Feb 9, 2023²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Terns Pharmaceuticals, Inc.2,250 shares³Nov 30, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Nov 30, 2024Bought 2,250 shares at $5.11 of Terns Pharmaceuticals, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTerns Pharmaceuticals, Inc., Chief Business Officer
2
SEC EDGARStructure Therapeutics Inc., Chief Business Officer
3
SEC EDGARTerns Pharmaceuticals, Inc. shares after the filing of Nov 30, 2024